Key Takeaways Stem cell therapy for rheumatoid arthritis has real human trial data behind it, not just lab or animal studies. A 3-year study found that disease activity scores significantly decreased in patients who received stem cells alongside standard medication. Mesenchymal stem cells appear to calm the immune response that
Key Takeaways Novartis paused eight autoimmune and nerve disease trials of its rap-cel CAR-T cell therapy on August 24, 2026. Three patients died from immune effector cell-associated hemophagocytic syndrome (IEC-HS). Bristol Myers Squibb had already paused its zola-cel autoimmune trials in early June after separate inflammatory reactions. No regulator has
Key Takeaways Researchers at MUSC report that engineered mesenchymal stem cells reversed new-onset type 1 diabetes in mice, pointing to the disease’s immune response rather than just its symptoms. The cells were modified to overexpress a protein called alpha-1 antitrypsin, which calmed the autoimmune attack and protected insulin producing beta
